Navigation Links
Thomson Healthcare Cancer Profiler Used in Study
Date:3/3/2008

Minority Interest in Clinical Trials Identified

STAMFORD, Conn., March 3 /PRNewswire-FirstCall/ -- When researching cancer treatment information, ethnic minorities are just as inclined as Caucasians to be interested in information about clinical trials, according to a study published in Journal of Cancer Research and Clinical Oncology. The study, "An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials," analyzed Internet use patterns among over 60,000 patients searching for information about cancer treatment.

Researchers from the University of Texas M.D. Anderson Cancer Center in Houston conducted the study by analyzing patient usage of Thomson Healthcare's (NYSE: TOC; TSX: TOC) online cancer profilers, which are embedded in over 100 cancer information Web sites, including the American Cancer Society's cancer.org. The online cancer profiler tools are free of charge and accessible under the "treatment decision" links on the American Cancer Society Web site. The tools allow patients and caregivers to enter detailed information about diagnoses and receive treatment options and information that can be used in the management of their conditions. One of the questions in the profiler is: "Are you interested in learning about clinical trials?" Researchers parsed the responses to this question against self-reported race/ethnicity data to come to the conclusion that African-American, Asian-American and Hispanic patients are just as inclined to indicate interest in clinical trials as their Caucasian counterparts.

"In this examination, more than 60,000 patients, who self-identified their race/ethnicity, responded to a question regarding their interest in learning more about cancer clinical trials. African-American, Hispanic and Asian- American patients expressed a similar level of interest compared to the Caucasian population," said Dr. Maurie Markman, M.D., lead author of the study and vice president for clinical research, M.D. Anderson Cancer Center. "These data raise the provocative suggestion that providing information regarding cancer trials may be a particularly rational method to spread awareness of these studies among the non-Caucasian patient populations."

According to the National Cancer Institute, minorities tend to be under- represented in health research studies. The institute suggests that efforts to increase minority participation in health research should focus on improving access to studies rather than on changing people's attitudes toward research.

"Clinical trials can be critical for the development of effective prevention, diagnostic and treatment methods for cancer and other diseases," said Alicia Moffat, vice president, Web operations, Thomson Healthcare. "We are pleased to learn that the data from our online cancer profilers has been helpful in providing people with access to the information they need about clinical trials as well as communicating the availability of this treatment option."

To learn more about this study, please contact D. Nikki Wheeler, nikki.wheeler@thomson.com or (303) 486-9031.

About Thomson Healthcare

Thomson Healthcare is the leading provider of decision support solutions that help organizations across the healthcare industry improve clinical and business performance. Thomson Healthcare products and services help clinicians, hospitals, employers; health plans, government agencies, and pharmaceutical companies manage the cost and improve the quality of healthcare. Thomson Healthcare is a part of The Thomson Corporation, a provider of value-added information, software tools and applications to professionals in the fields of healthcare, law, tax, accounting, scientific research, and financial services. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC). For more information, visit (http://www.thomsonhealthcare.com ).


'/>"/>
SOURCE Thomson Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
3. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. ViroPharma to Present at Three Upcoming Healthcare Conferences
7. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
8. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
9. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
10. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
11. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... , ... "FCPX editors can now reveal their media with growing colorful split ... Austin - CEO of Pixel Film Studios. , ProSlice Color brings the split ... now reveal the media of their split screens with growing colorful panels. , ProSlice ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
Breaking Medicine News(10 mins):